Hemodynamic monitoring System Market Research Report and Outlook by 2028

The hemodynamic monitoring system market is projected to grow from US$ 1,419.94 million in 2021 to US$ 2,173.15 million by 2028, reflecting a compound annual growth rate (CAGR) of 6.4% from 2022 to 2028.

The primary drivers of this market include the increasing elderly population worldwide and the growing preference for minimally invasive procedures. However, the potential risks associated with invasive hemodynamic monitoring systems pose challenges to market expansion.

Hemodynamic monitoring systems are essential for assessing blood flow within the cardiovascular system, which encompasses the heart and blood vessels. These systems enable healthcare professionals to evaluate the oxygen distribution to various tissues and organs in the body. Additionally, they are utilized to monitor blood pressure within veins, arteries, and the heart, as well as to determine blood oxygen levels.

Cardiovascular diseases (CVDs) rank as the leading cause of mortality globally, resulting in millions of deaths annually. According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet from the Global Burden of Disease, around 119.1 million individuals succumbed to cardiovascular diseases in 2020. The report also highlighted that the global incidence of stroke and ischemic stroke reached 89.1 million and 68.2 million, respectively, in the same year. Key contributors to cardiovascular diseases include hypertension, obesity, and diabetes.

In North America, the prevalence of cardiovascular diseases is notably high. The National Center for Chronic Disease Prevention and Health Promotion reported that approximately 697,000 individuals in the United States died from heart disease in 2020, equating to one in every five deaths. Furthermore, the American Heart Association predicts that by 2035, over 130 million Americans, or 45.1% of the population, will be affected by some form of cardiovascular disease. In Europe, CVDs are also a significant health concern, accounting for 45% of total deaths across the continent and 37% within the European Union.

Moreover, over 75% of CVD-related fatalities occur in low- and middle-income nations, where high blood pressure is a predominant risk factor. The "Global Burden of Disease Study 2019" indicated that CVD was the leading cause of death in Asia, resulting in 10.8 million deaths (approximately 35% of total deaths) in 2019. Consequently, the increasing incidence of cardiovascular diseases is a major factor propelling the hemodynamic monitoring market.

Type Insights

The global hemodynamic monitoring system market is categorized into three types: noninvasive, minimally invasive, and invasive hemodynamic monitoring systems. In 2021, the invasive hemodynamic monitoring system segment dominated the market share. However, the noninvasive monitoring system segment is anticipated to experience the highest growth rate during the forecast period from 2022 to 2028. Noninvasive hemodynamic monitoring systems typically utilize an air-filled band that can assess blood pressure both manually and automatically, offering the advantage of speed without the need for a stethoscope.

Product Insight

The global hemodynamic monitoring system market is further divided into monitors and disposables based on product type. In 2021, the disposables segment held the largest market share. Nevertheless, the monitors segment is expected to register the highest CAGR during the 2022-2028 forecast period. Factors contributing to this growth include the rising prevalence of cardiovascular diseases, advancements in monitoring technology, increased government funding for patient-centered safety and care, and the ability of hemodynamic monitors to enhance the efficiency of catheterization labs.

End User Insights

The hemodynamic monitoring system market is segmented by end user into hospitals, catheterization labs, home care settings, and ambulatory surgical centers. The hospital segment accounted for the largest market share in 2021 and is projected to maintain its leading position by 2028. Hospitals are critical facilities equipped with comprehensive resources, offering a range of diagnostic and treatment services that are often covered by insurance. They provide essential care, physiotherapy, and support that facilitate quicker patient recovery. Additionally, hospitals are equipped with advanced technology and integrated information systems.

Hospitals are responsible for all diagnostics and treatments related to cardiovascular diseases, which necessitate continuous monitoring and high-quality nursing services. Given these factors, the hospital segment of the market is expected to see significant growth in the coming years.